Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.82547 | 35 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.79775 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.80779 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.7379 | 35 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.74221 | 35 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.88258 | 35 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.83258 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.77102 | 34 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.7414 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.78204 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.78193 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.7627 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.79012 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78586 | 35 |